Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients
Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients
Recruiting · NCT05732051 · Registry updated 2023-03-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, cardiovascular disorder, heart disorder, heart failure, injury, neoplasm, radiation injury, skin disorder | Recruiting | Phase 2 | 2023-03-17 | NCT05732051 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ChromaDex, Inc. | 5 |
| Helse Sor-Ost | 9 |
| Norwegian Breast Cancer Association | 1 |
| Norwegian Cancer Society | 12 |
| University Hospital, Akershus | 87 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Akershus University Hospital | Lørenskog | Norway | 9 |